Skip to main content
Monday, November 16, 2026Nov 16

Stock market’s recovery is led by drugmakers

FILE - This July 12, 2012 file photo shows Centrum multivitamins on the packaging line at the Pfizer plant in Montreal. Health care companies are leading the market's rebound from a sharp sell-off two weeks ago, helping push the Dow Jones industrial average and Standard & Poor's 500 index back to record levels. (AP Photo/The Canadian Press, Graham Hughes, File)
FILE - This July 12, 2012 file photo shows Centrum multivitamins on the packaging line at the Pfizer plant in Montreal. Health care companies are leading the market's rebound from a sharp sell-off two weeks ago, helping push the Dow Jones industrial average and Standard & Poor's 500 index back to record levels. (AP Photo/The Canadian Press, Graham Hughes, File)

NEW YORK (AP) – For stocks, it’s just what the doctor ordered.

Health care companies are leading the market’s rebound from a sharp sell-off two weeks ago, helping push the Dow Jones industrial average and Standard & Poor’s 500 index back to record levels.

The industry, which is made up of a range of companies, from global drugmakers like Pfizer to insurers like UnitedHealth, has risen 11.2 percent since October 15, when the stock market’s recent slump hit bottom. That is a bigger rise than the 8.4 percent gain for the broader market.

The sector’s surge has been driven by its strong third-quarter earnings.

About two-thirds of companies in the S&P 500 have now turned in results, and the health care industry is on track to have the best earnings growth, according to data from Estimize, a company that gathers forecasts from a range of financial professionals.